Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRI Study of Blood-brain Barrier Function in CADASIL

NCT05902039 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT05902039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05902039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRI Study of Blood-brain Barrier Function in CADASIL
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2021
Completion date
April 1, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood brain barrier defect, cadasil